Stock listing
BOATS:ARTV Artiva Biotherapeutics, Inc. Stock
US listing (BOATS) of Artiva Biotherapeutics, Inc. · home listing NASDAQ:ARTV
Follow Artiva Biotherapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ARTV
$4.15 USD +0.02 (+0.5%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ARTV
- Day range
- $4.13 – $4.24 USDNov 6, 2026
- Volume
- 908,723 sharesNov 6, 2026
- Market cap
- $202.9M USDAt the close on Nov 6, 2026 · price × 48.89M shares outstanding
- 52-week range
- $2.96 – $14.53 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $4.28M USDMedian day 422,663 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ARTV · Home | $4.15 USD | +0.02 (+0.5%) | 908,723 | $4.16 | $4.24 | $4.13 | $4.13 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:ARTV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.15 | +0.02 | +0.5% | $4.16 | $4.24 | $4.13 | 908,723 | |
| $4.13 | -0.09 | -2.1% | $4.19 | $4.22 | $4.07 | 976,833 | |
| $4.22 | +0.02 | +0.5% | $4.25 | $4.28 | $4.16 | 754,021 | |
| $4.20 | +0.01 | +0.2% | $4.24 | $4.25 | $4.155 | 623,313 | |
| $4.19 | 0.00 | 0.0% | $4.21 | $4.24 | $4.14 | 938,152 | |
| $4.19 | -0.04 | -0.9% | $4.20 | $4.26 | $4.10 | 1,966,165 | |
| $4.23 | -0.045 | -1.1% | $4.22 | $4.27 | $4.153 | 1,890,513 | |
| $4.275 | +0.005 | +0.1% | $4.35 | $4.39 | $4.22 | 2,884,135 | |
| $4.27 | -1.89 | -30.7% | $4.25 | $4.45 | $4.00 | 8,673,746 | |
| $6.16 | +0.01 | +0.2% | $6.15 | $6.25 | $5.95 | 487,078 | |
| $6.15 | -0.05 | -0.8% | $6.16 | $6.17 | $5.95 | 315,489 | |
| $6.20 | -0.29 | -4.5% | $6.38 | $6.65 | $6.16 | 393,902 | |
| $6.49 | -0.07 | -1.1% | $6.60 | $6.74 | $6.44 | 363,943 | |
| $6.56 | +0.67 | +11.4% | $5.89 | $6.65 | $5.86 | 449,925 | |
| $5.89 | +0.04 | +0.7% | $5.97 | $6.20 | $5.76 | 536,922 | |
| $5.85 | -0.21 | -3.5% | $6.08 | $6.10 | $5.82 | 573,256 | |
| $6.06 | +0.15 | +2.5% | $5.93 | $6.16 | $5.85 | 478,246 | |
| $5.91 | -0.38 | -6.0% | $6.21 | $6.25 | $5.88 | 707,557 | |
| $6.29 | -0.48 | -7.1% | $6.74 | $6.74 | $6.236 | 526,968 | |
| $6.77 | -0.17 | -2.4% | $6.92 | $6.943 | $6.73 | 248,580 | |
| $6.94 | +0.14 | +2.1% | $6.84 | $7.135 | $6.77 | 275,938 | |
| $6.80 | -0.20 | -2.9% | $6.89 | $6.92 | $6.575 | 339,711 | |
| $7.00 | -0.27 | -3.7% | $7.10 | $7.27 | $6.84 | 324,576 | |
| $7.27 | +0.14 | +2.0% | $7.12 | $7.38 | $6.92 | 665,416 | |
| $7.13 | +0.30 | +4.4% | $6.75 | $7.16 | $6.52 | 473,192 | |
| $6.83 | +0.04 | +0.6% | $6.89 | $7.00 | $6.74 | 587,649 | |
| $6.79 | -0.33 | -4.6% | $7.11 | $7.15 | $6.77 | 444,372 | |
| $7.12 | +0.09 | +1.3% | $7.10 | $7.40 | $6.96 | 383,976 | |
| $7.03 | -0.02 | -0.3% | $7.06 | $7.18 | $6.92 | 450,565 | |
| $7.05 | +0.06 | +0.9% | $6.91 | $7.185 | $6.75 | 437,532 | |
| $6.99 | -0.50 | -6.7% | $7.48 | $7.49 | $6.90 | 507,137 | |
| $7.49 | -0.23 | -3.0% | $7.62 | $7.71 | $7.22 | 511,722 | |
| $7.72 | -0.37 | -4.6% | $7.99 | $8.20 | $7.52 | 407,794 | |
| $8.09 | +0.26 | +3.3% | $7.87 | $8.39 | $7.855 | 437,976 | |
| $7.83 | -0.78 | -9.1% | $8.63 | $8.64 | $7.78 | 629,415 | |
| $8.61 | +0.17 | +2.0% | $8.45 | $8.75 | $8.40 | 2,208,401 | |
| $8.44 | -0.16 | -1.9% | $8.66 | $8.72 | $8.35 | 456,517 | |
| $8.60 | -0.31 | -3.5% | $8.89 | $9.03 | $8.485 | 516,987 | |
| $8.91 | -1.23 | -12.1% | $10.05 | $10.05 | $8.84 | 584,582 | |
| $10.14 | -0.08 | -0.8% | $10.21 | $10.55 | $10.13 | 243,866 | |
| $10.22 | -0.20 | -1.9% | $10.49 | $10.61 | $10.10 | 228,437 | |
| $10.42 | -0.37 | -3.4% | $10.70 | $10.93 | $10.36 | 449,476 | |
| $10.79 | -0.09 | -0.8% | $10.78 | $11.15 | $10.73 | 325,338 | |
| $10.88 | -0.31 | -2.8% | $10.83 | $11.16 | $10.70 | 211,697 | |
| $11.19 | +0.065 | +0.6% | $11.02 | $11.34 | $10.94 | 168,592 | |
| $11.13 | -0.185 | -1.6% | $11.34 | $11.35 | $10.98 | 365,624 | |
| $11.31 | +0.03 | +0.3% | $11.26 | $11.51 | $11.05 | 306,518 | |
| $11.28 | -0.02 | -0.2% | $11.00 | $11.36 | $10.88 | 268,855 | |
| $11.30 | +0.21 | +1.9% | $11.01 | $11.35 | $10.88 | 249,844 | |
| $11.09 | -0.85 | -7.1% | $11.78 | $11.80 | $11.00 | 223,493 | |
| $11.94 | +0.17 | +1.4% | $11.72 | $12.08 | $11.56 | 218,273 | |
| $11.77 | 0.00 | 0.0% | $11.75 | $11.93 | $11.60 | 262,556 | |
| $11.77 | +0.25 | +2.2% | $11.60 | $11.91 | $11.53 | 266,361 | |
| $11.52 | +0.59 | +5.4% | $10.83 | $11.70 | $10.49 | 307,236 | |
| $10.93 | -0.21 | -1.9% | $11.26 | $11.60 | $10.76 | 199,424 | |
| $11.14 | -0.56 | -4.8% | $11.50 | $11.58 | $10.93 | 319,084 | |
| $11.70 | +0.02 | +0.2% | $11.69 | $11.85 | $11.21 | 457,997 | |
| $11.68 | -0.06 | -0.5% | $11.52 | $12.00 | $11.52 | 261,929 | |
| $11.74 | +0.29 | +2.5% | $11.45 | $11.84 | $11.10 | 288,779 | |
| $11.45 | +0.15 | +1.3% | $11.24 | $11.59 | $10.80 | 264,416 | |
| $11.30 | -0.23 | -2.0% | $11.59 | $11.76 | $11.22 | 253,286 | |
| $11.53 | -0.25 | -2.1% | $11.74 | $12.10 | $11.51 | 275,200 | |
| $11.78 | +0.56 | +5.0% | $11.18 | $12.27 | $11.02 | 456,610 | |
| $11.22 | -0.05 | -0.4% | $11.12 | $11.46 | $11.02 | 178,961 | |
| $11.27 | -0.31 | -2.7% | $11.63 | $11.98 | $10.75 | 214,691 | |
| $11.58 | -0.01 | -0.1% | $11.52 | $12.06 | $11.38 | 321,639 |
- Ticker
- BOATS:ARTV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
Latest deck · Sep 23, 2026
17th International Symposium on Sjögren's Disease 2026
Conference · 18 slides
Latest news
Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
Oct 27, 2026
Closed $4.27 (-30.7%) on Oct 27, 2026
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
Oct 2, 2026
Closed $6.83 (+0.6%) on Oct 2, 2026
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
Oct 1, 2026
Closed $6.79 (-4.6%) on Oct 1, 2026
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease
Sep 23, 2026
Closed $7.72 (-4.6%) on Sep 23, 2026
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Sep 17, 2026
Closed $8.44 (-1.9%) on Sep 17, 2026
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
Sep 8, 2026
Closed $10.88 (-2.8%) on Sep 8, 2026
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Sep 2, 2026
Closed $11.31 (+0.3%) on Sep 2, 2026
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Aug 6, 2026
Closed $11.27 (-2.7%) on Aug 7, 2026
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jul 17, 2026
Closed $9.76 (+8.0%) on Jul 17, 2026
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Jun 23, 2026
Closed $9.32 (-4.9%) on Jun 24, 2026
Decks
17th International Symposium on Sjögren's Disease 2026
Conference · 18 slides · Sep 23, 2026
Post-EULAR Virtual Webcast (June 2026)
Conference · 37 slides · Jun 8, 2026
EULAR 2026
Conference · 15 slides · Jun 6, 2026
EULAR 2026
Conference · 15 slides · Jun 3, 2026
Artiva Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 39 in all · newest Oct 27, 2026 · oldest 2024
- Decks
- 7 decks · latest Sep 23, 2026
Where Artiva Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ARTV · Home listing | NASDAQ | United States | USD |
| BOATS:ARTV · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Artiva Biotherapeutics, Inc.